Maverick Capital affiliates re-invest in Nodality
Clients Maverick Capital Ltd.
Jones Day advised affiliates of Maverick Capital Ltd. in connection with their purchase of Series B Preferred Stock in an expected $10 million private placement by Nodality, Inc., a biotechnology company developing next generation personal diagnostics focused on cell pathways. Co-investors include Kleiner Perkins Caufield & Byers and TPG Biotechnology.